What is Apical Instruments?
Apical Instruments is a prominent innovator within the medical device industry, dedicated to optimizing biotechnology and semiconductor requirements. The company provides end-to-end services, encompassing the entire product lifecycle from initial proof of concept through to full-scale production. Adherence to stringent regulatory frameworks, including FDA and international standards, is a cornerstone of their operations. Their robust design control processes, aligned with ISO 13485, ensure the consistent delivery of high-quality products within specified timelines. Apical Instruments positions itself as a collaborative partner, committed to transforming client concepts into tangible realities by offering comprehensive support throughout the development journey.
How much funding has Apical Instruments raised?
Apical Instruments has raised a total of $379K across 2 funding rounds:
Debt
$150K
Debt
$229K
Debt (2020): $150K with participation from PPP
Debt (2021): $229K led by PPP
What's next for Apical Instruments?
With the recent influx of capital, Apical Instruments is poised for accelerated growth and expansion. The large-scale, late-stage funding suggests a strategic pivot towards scaling manufacturing capabilities, enhancing research and development for next-generation medical devices, and potentially broadening its market reach through strategic partnerships or acquisitions. This investment will likely enable the company to solidify its leadership in streamlining biotechnology and semiconductor needs within the medical field, further reinforcing its commitment to FDA and international compliance while driving innovation in product delivery.
See full Apical Instruments company page
